Blood test guides Post-Surgery chemo in esophageal cancer trial
NCT ID NCT06914011
First seen Jan 02, 2026 · Last updated Apr 28, 2026 · Updated 22 times
Summary
This study tests whether using a blood test (circulating tumor DNA) to decide who gets extra chemotherapy after surgery can help prevent esophageal cancer from coming back. About 172 adults with resected esophageal cancer will either receive chemo plus tisleliizumab or just be monitored. The goal is to see if the guided treatment improves how long people stay cancer-free.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.